Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 162

1.

Dynamic contrast-enhanced MRI of nasopharyngeal carcinoma: a preliminary study of the correlations between quantitative parameters and clinical stage.

Zheng D, Chen Y, Chen Y, Xu L, Chen W, Yao Y, Du Z, Deng X, Chan Q.

J Magn Reson Imaging. 2014 Apr;39(4):940-8. doi: 10.1002/jmri.24249. Epub 2013 Sep 24.

PMID:
24108569
2.

[Relationship between parameters of dynamic contrast-enhanced MRI and clinical stage of nasopharyngeal carcinoma].

Yu X, Li F, Hu Y, Lu Q, Wang H.

Zhonghua Zhong Liu Za Zhi. 2015 Aug;37(8):597-602. Chinese.

PMID:
26714600
3.

Correlation of dynamic contrast-enhanced MRI perfusion parameters with angiogenesis and biologic aggressiveness of rectal cancer: Preliminary results.

Yeo DM, Oh SN, Jung CK, Lee MA, Oh ST, Rha SE, Jung SE, Byun JY, Gall P, Son Y.

J Magn Reson Imaging. 2015 Feb;41(2):474-80. doi: 10.1002/jmri.24541. Epub 2013 Dec 21.

PMID:
24375840
4.

Dynamic contrast-enhanced magnetic resonance imaging for characterising nasopharyngeal carcinoma: comparison of semiquantitative and quantitative parameters and correlation with tumour stage.

Huang B, Wong CS, Whitcher B, Kwong DL, Lai V, Chan Q, Khong PL.

Eur Radiol. 2013 Jun;23(6):1495-502. doi: 10.1007/s00330-012-2740-7. Epub 2013 Feb 2.

PMID:
23377545
5.

Feasibility and value of quantitative dynamic contrast enhancement MR imaging in the evaluation of sinonasal tumors.

Xian J, Du H, Wang X, Yan F, Zhang Z, Hao H, Zhao B, Tong Y, Zhang J, Han D.

Chin Med J (Engl). 2014;127(12):2259-64.

PMID:
24931238
6.

Early response to chemoradiotherapy for nasopharyngeal carcinoma treatment: Value of dynamic contrast-enhanced 3.0 T MRI.

Zheng D, Chen Y, Liu X, Chen Y, Xu L, Ren W, Chen W, Chan Q.

J Magn Reson Imaging. 2015 Jun;41(6):1528-40. doi: 10.1002/jmri.24723. Epub 2014 Aug 18.

PMID:
25136770
7.

Dynamic contrast-enhanced magnetic resonance imaging measurements in renal cell carcinoma: effect of region of interest size and positioning on interobserver and intraobserver variability.

Braunagel M, Radler E, Ingrisch M, Staehler M, Schmid-Tannwald C, Rist C, Nikolaou K, Reiser MF, Notohamiprodjo M.

Invest Radiol. 2015 Jan;50(1):57-66. doi: 10.1097/RLI.0000000000000096.

PMID:
25260094
8.

Early responses assessment of neoadjuvant chemotherapy in nasopharyngeal carcinoma by serial dynamic contrast-enhanced MR imaging.

Zheng D, Yue Q, Ren W, Liu M, Zhang X, Lin H, Lai G, Chen W, Chan Q, Chen Y.

Magn Reson Imaging. 2017 Jan;35:125-131. doi: 10.1016/j.mri.2016.08.011. Epub 2016 Aug 29.

PMID:
27587228
9.

Assessment of liver fibrosis using pharmacokinetic parameters of dynamic contrast-enhanced magnetic resonance imaging.

Li Z, Sun J, Chen L, Huang N, Hu P, Hu X, Han G, Zhou Y, Bai W, Niu T, Yang X.

J Magn Reson Imaging. 2016 Jul;44(1):98-104. doi: 10.1002/jmri.25132. Epub 2015 Dec 28.

PMID:
26707910
10.

Quantitative dynamic contrast-enhanced and diffusion-weighted MRI for differentiation between nasopharyngeal carcinoma and lymphoma at the primary site.

Yu XP, Hou J, Li FP, Xiang W, Lu Q, Hu Y, Wang H.

Dentomaxillofac Radiol. 2016;45(3):20150317. doi: 10.1259/dmfr.20150317. Epub 2016 Feb 5.

11.

Intravoxel incoherent motion MR imaging in nasopharyngeal carcinoma: comparison and correlation with dynamic contrast enhanced MR imaging.

Lai V, Lee VHF, Lam KO, Huang B, Chan Q, Khong PL.

Oncotarget. 2017 Jul 26;8(40):68472-68482. doi: 10.18632/oncotarget.19575. eCollection 2017 Sep 15.

12.

A comparison of arterial spin labeling perfusion MRI and DCE-MRI in human prostate cancer.

Cai W, Li F, Wang J, Du H, Wang X, Zhang J, Fang J, Jiang X.

NMR Biomed. 2014 Jul;27(7):817-25. doi: 10.1002/nbm.3124. Epub 2014 May 9.

PMID:
24809332
13.

[Influences of magnetic resonance imaging on the staging system of nasopharyngeal carcinoma].

Sun Y, Mao YP, Ma J, Huang Y, Tang LL, Wang Y, Liu LZ, Lu TX.

Ai Zheng. 2007 Feb;26(2):158-63. Chinese.

PMID:
17298745
14.

Optimizing MRI scan time in the computation of pharmacokinetic parameters (K(trans) ) in breast cancer diagnosis.

Jena A, Mehta SB, Taneja S.

J Magn Reson Imaging. 2013 Sep;38(3):573-9. doi: 10.1002/jmri.24008. Epub 2013 Jan 24.

PMID:
23349046
15.

Comparison of quantitative and semiquantitative dynamic contrast-enhanced MRI with respect to their correlation to delayed gadolinium-enhanced MRI of the cartilage in patients with early rheumatoid arthritis.

Müller-Lutz A, Schleich C, Sewerin P, Gross J, Pentang G, Wittsack HJ, Antoch G, Schneider M, Ostendorf B, Miese F.

J Comput Assist Tomogr. 2015 Jan-Feb;39(1):64-9. doi: 10.1097/RCT.0000000000000164.

PMID:
25340588
16.

Reproducibility of the aortic input function (AIF) derived from dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) of the kidneys in a volunteer study.

Mendichovszky IA, Cutajar M, Gordon I.

Eur J Radiol. 2009 Sep;71(3):576-81. doi: 10.1016/j.ejrad.2008.09.025. Epub 2008 Nov 11.

PMID:
19004588
17.

Combining dynamic contrast enhanced magnetic resonance imaging and microvessel density to assess the angiogenesis after PEI in a rabbit VX2 liver tumor model.

Chen J, Qian T, Zhang H, Wei C, Meng F, Yin H.

Magn Reson Imaging. 2016 Feb;34(2):177-82. doi: 10.1016/j.mri.2015.10.013. Epub 2015 Oct 27.

PMID:
26518059
18.

Dynamic contrast-enhanced magnetic resonance imaging for pancreatic ductal adenocarcinoma at 3.0-T magnetic resonance: correlation with histopathology.

Liu K, Xie P, Peng W, Zhou Z.

J Comput Assist Tomogr. 2015 Jan-Feb;39(1):13-8. doi: 10.1097/RCT.0000000000000171.

PMID:
25340589
20.

Dynamic contrast-enhanced MRI of gastric cancer: Correlation of the perfusion parameters with pathological prognostic factors.

Joo I, Lee JM, Han JK, Yang HK, Lee HJ, Choi BI.

J Magn Reson Imaging. 2015 Jun;41(6):1608-14. doi: 10.1002/jmri.24711. Epub 2014 Jul 16.

PMID:
25044978

Supplemental Content

Support Center